0001127602-21-019456.txt : 20210608
0001127602-21-019456.hdr.sgml : 20210608
20210608184422
ACCESSION NUMBER: 0001127602-21-019456
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210607
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ANSTICE DAVID W
CENTRAL INDEX KEY: 0001181171
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35299
FILM NUMBER: 211003413
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alkermes plc.
CENTRAL INDEX KEY: 0001520262
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981007018
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
BUSINESS PHONE: 00-353-1-772-8000
MAIL ADDRESS:
STREET 1: CONNAUGHT HOUSE
STREET 2: 1 BURLINGTON ROAD
CITY: DUBLIN 4
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: ANTLER SCIENCE TWO PLC
DATE OF NAME CHANGE: 20110804
FORMER COMPANY:
FORMER CONFORMED NAME: Antler Science Two Ltd
DATE OF NAME CHANGE: 20110509
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-06-07
0001520262
Alkermes plc.
ALKS
0001181171
ANSTICE DAVID W
CONNAUGHT HOUSE
1 BURLINGTON ROAD
DUBLIN 4 IRELAND
1
Ordinary Shares
2021-06-07
4
M
0
5000
14.60
A
78081
D
Ordinary Shares
2021-06-07
4
S
0
5000
24.00
D
73081
D
Non Qualified Stock Option (Right to Buy)
14.60
2021-06-07
4
M
0
5000
0
D
2021-10-05
Ordinary Shares
5000
20000
D
This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
These options are fully vested in accordance with their terms.
/s/ Shantale Greenson, attorney-in-fact for David W. Anstice
2021-06-08